Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Nutritional recovery with a soybean diet after weaning reduces lipogenesis but induces inflammation in the liver in adult rats exposed to protein restriction during intrauterine life and lactation.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 9209001 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1466-1861 (Electronic) Linking ISSN: 09629351 NLM ISO Abbreviation: Mediators Inflamm Subsets: MEDLINE
    • بيانات النشر:
      Publication: 2005- : Sylvania, OH : Hindawi Pub. Corp.
      Original Publication: Oxford, UK : Rapid Communications of Oxford Ltd., c1992-
    • الموضوع:
    • نبذة مختصرة :
      We evaluated the effects of postweaning nutritional recovery with a soybean flour diet on de novo hepatic lipogenesis and inflammation in adult rats exposed to protein restriction during intrauterine life and lactation. Rats from mothers fed with protein (casein) in a percentage of 17% (control, C) or 6% (low, L) during pregnancy and lactation were fed with diet that contained 17% casein (CC and LC groups, resp.) or soybean (CS and LS groups, resp.) after weaning until 90 days of age. LS and CS rats had low body weight, normal basal serum triglyceride levels, increased ALT concentrations, and high HOMA-IR indices compared with LC and CC rats. The soybean diet reduced PPARγ as well as malic enzyme and citrate lyase contents and activities. The lipogenesis rate and liver fat content were lower in LS and CS rats relative to LC and CC rats. TNFα mRNA and protein levels were higher in LS and CS rats than in LC and CC rats. NF-κB mRNA levels were lower in the LC and LS groups compared with the CC and LC groups. Thus, the soybean diet prevented hepatic steatosis at least in part through reduced lipogenesis but resulted in TNFα-mediated inflammation.
    • References:
      Science. 2001 Mar 30;291(5513):2613-6. (PMID: 11283375)
      PLoS One. 2009;4(11):e7929. (PMID: 19936233)
      J Biol Chem. 2001 Oct 19;276(42):38337-40. (PMID: 11546755)
      Hepatology. 2001 Dec;34(6):1158-63. (PMID: 11732005)
      Endocr Rev. 2002 Apr;23(2):201-29. (PMID: 11943743)
      N Engl J Med. 2002 Apr 18;346(16):1221-31. (PMID: 11961152)
      Diabetes. 2002 Jun;51(6):1889-95. (PMID: 12031978)
      J Lipid Res. 1999 Jul;40(7):1177-84. (PMID: 10393202)
      J Biol Chem. 1999 Oct 15;274(42):30028-32. (PMID: 10514488)
      FEBS Lett. 2010 Mar 5;584(5):995-1000. (PMID: 20102709)
      Nutrition. 2010 Apr;26(4):441-8. (PMID: 19880292)
      Cell Metab. 2011 Jan 5;13(1):11-22. (PMID: 21195345)
      Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):108-18. (PMID: 21293511)
      Lipids Health Dis. 2012;11:2. (PMID: 22221448)
      Br J Nutr. 2012 Sep 28;108(6):1042-51. (PMID: 22152781)
      Nutr Res. 2013 Jun;33(6):494-502. (PMID: 23746566)
      J Endocrinol. 2013 Sep;218(3):R25-36. (PMID: 23833274)
      Am J Med. 1999 Nov;107(5):450-5. (PMID: 10569299)
      Am J Physiol Endocrinol Metab. 2002 Nov;283(5):E1016-22. (PMID: 12376330)
      J Clin Invest. 2003 Mar;111(5):737-47. (PMID: 12618528)
      Hepatology. 2003 May;37(5):1202-19. (PMID: 12717402)
      J Nutr. 2003 May;133(5):1238-43. (PMID: 12730403)
      Hepatology. 2003 Jul;38(1):123-32. (PMID: 12829994)
      J Biol Chem. 2003 Sep 5;278(36):34268-76. (PMID: 12805374)
      J Nutr. 2004 Mar;134(3):522-9. (PMID: 14988441)
      Cell Mol Life Sci. 2004 Feb;61(4):393-416. (PMID: 14999402)
      Mol Cell Endocrinol. 2004 May 31;220(1-2):51-8. (PMID: 15196699)
      J Clin Invest. 2004 Jul;114(2):147-52. (PMID: 15254578)
      Nature. 1970 Aug 15;227(5259):680-5. (PMID: 5432063)
      Anal Biochem. 1976 May 7;72:248-54. (PMID: 942051)
      Diabetologia. 1981 Nov;21(5):470-5. (PMID: 7028561)
      Anat Rec. 1988 Mar;220(3):300-4. (PMID: 3284417)
      Am J Physiol. 1996 Apr;270(4 Pt 1):E559-64. (PMID: 8928759)
      Z Naturforsch C. 1996 Nov-Dec;51(11-12):859-69. (PMID: 9031527)
      J Biol Chem. 1997 Aug 8;272(32):20108-17. (PMID: 9242684)
      J Clin Invest. 1997 Dec 1;100(11):2858-64. (PMID: 9389752)
      J Nutr. 1998 Oct;128(10):1643-9. (PMID: 9772130)
      Mol Cell Biol. 1999 May;19(5):3760-8. (PMID: 10207099)
      J Biol Chem. 1957 May;226(1):497-509. (PMID: 13428781)
      J Biol Chem. 1959 Oct;234:2544-7. (PMID: 13833535)
      Am J Clin Nutr. 2005 Feb;81(2):397-408. (PMID: 15699227)
      CMAJ. 2005 Mar 29;172(7):899-905. (PMID: 15795412)
      J Clin Invest. 2005 May;115(5):1343-51. (PMID: 15864352)
      Hepatology. 2005 Oct;42(4):905-14. (PMID: 16175602)
      Reprod Biol Endocrinol. 2005;3:58. (PMID: 16250912)
      Food Chem Toxicol. 2006 Jan;44(1):56-80. (PMID: 16213646)
      J Nutr Biochem. 2006 Jun;17(6):365-73. (PMID: 16481155)
      J Nutr. 2007 May;137(5):1127-31. (PMID: 17449569)
      Clin Liver Dis. 2007 Feb;11(1):25-35, viii. (PMID: 17544970)
      Hepatology. 2007 Jun;45(6):1366-74. (PMID: 17476695)
      World J Gastroenterol. 2007 Jul 14;13(26):3540-53. (PMID: 17659704)
      Nutrition. 2008 Jan;24(1):76-83. (PMID: 18070660)
      Am J Clin Pathol. 1948 Sep;18(9):723-30. (PMID: 18885493)
      J Nutr Biochem. 2008 Nov;19(11):778-84. (PMID: 18430554)
      Nutrition. 2009 Jul-Aug;25(7-8):774-81. (PMID: 19251398)
      J Biol Chem. 2001 Oct 5;276(40):37402-8. (PMID: 11445560)
    • الرقم المعرف:
      0 (Insulin)
      0 (Lipids)
      0 (Multienzyme Complexes)
      0 (NF-kappa B)
      0 (PPAR gamma)
      0 (RNA, Messenger)
      0 (Sterol Regulatory Element Binding Protein 1)
      EC 4.1.3.- (Oxo-Acid-Lyases)
      EC 4.1.3.6 (citrate (pro-3S)-lyase)
    • الموضوع:
      Date Created: 20150421 Date Completed: 20160201 Latest Revision: 20231213
    • الموضوع:
      20231215
    • الرقم المعرف:
      PMC4393912
    • الرقم المعرف:
      10.1155/2015/781703
    • الرقم المعرف:
      25892856